Engineering in Medicine Symposium
Integrating Engineering Design, Evidence-based Medicine, and Cost-Effectiveness
October 16-17, 2008
Thayer School of Engineering
Spanos Auditorium, Cummings Hall
Videos of this event are posted on the program page.
New technologies have the potential to reduce healthcare costs, improve quality of life and save lives, yet some technologies present the risk of substantial increases in healthcare costs through improper development or implementation. Advances in diagnostic imaging, drug development, implants and intervention must be designed within the context of their value in terms of society's expectations, cost-effectiveness, benefits, and balanced with the potential for producing paradigm shifts in healthcare. There is increased pressure in the U.S. towards the integration of engineering design into cost-effective universal healthcare with societal benefit, yet this must be balanced with support for a process which fosters rapid advances in technological innovation.
Evidence based medicine is the process of using the best practices in the scientific method to analyze clinical outcomes for the determination of what should be standard medical practice. New technologies are ultimately tested for medical efficacy, but the process of utilizing medical evidence back into engineering design is less well developed. This symposium is designed to explore the Technological Roadmap of how to complete the iterative process, using the best practices in medical outcomes and cost-effectiveness analysis to inform the engineering design processes, within the context of sustainable improvements in universal healthcare.
For more information, contact Professor Brian Pogue.
- Roderic Pettigrew, M.D., Ph.D., Director, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health
- Ronald Newbower, Ph.D., Strategic Director and Chief Technology Officer, Center for Integration of Medicine and Innovative Technology
- C. Everett Koop, M.D., Senior Scholar, C. Everett Koop Institute
- Robert Langer, Ph.D., Institute Professor, Massachusetts Institute of Technology
- Terry McGuire, M.S., MBA, Co-founder and Managing General Partner, Polaris Ventures
- Michael Ross, Ph.D., Managing Partner, SV Life Sciences
- Julie Shimer, Ph.D., President & CEO, Welch Allyn
- Robert Sprinkle, M.D., Ph.D., Associate Professor, Public Policy, University of Maryland
- Milton Weinstein, Ph.D., Professor, Harvard University